Study Spotlight

Study Spotlight

Lutein Reduce Plasma Lipid Peroxidation and C-reactive Protein in Healthy Nonsmokers


In a randomized, double-blind, placebo-controlled trial conducted in 117 healthy nonsmokers, supplementation with lutein (10 or 20 mg/d) for a period of 12 weeks was found to be associated with significant increases in plasma lutein levels and TAOC, and a dose-dependent decrease in CRP. In the 20 mg/d group, a significant reduction in malondialdehyde was found as well. The authors conclude, "The results support the possibility that lutein supplementation reduce biomarkers of CVD risk via decreased lipid peroxidation and inflammatory response by increasing plasma lutein concentrations and antioxidant capacity.

Click Here to visit the journal website. Subscription required to view the full text of the article.

Socialize
Website by Webfitters